215 related articles for article (PubMed ID: 37542052)
1. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.
Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
[TBL] [Abstract][Full Text] [Related]
2. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
4. Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer.
Shangguan X; Ma Z; Yu M; Ding J; Xue W; Qi J
Cancer Res; 2022 Sep; 82(17):3032-3044. PubMed ID: 35767703
[TBL] [Abstract][Full Text] [Related]
5. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling.
He L; Li H; Pan C; Hua Y; Peng J; Zhou Z; Zhao Y; Lin M
Cancer Commun (Lond); 2021 Aug; 41(8):726-746. PubMed ID: 34268906
[TBL] [Abstract][Full Text] [Related]
6. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract][Full Text] [Related]
7. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
9. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
[TBL] [Abstract][Full Text] [Related]
10. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma.
Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J
Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482
[TBL] [Abstract][Full Text] [Related]
12. Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC.
Zhao X; Guo B; Sun W; Yu J; Cui L
Adv Sci (Weinh); 2023 Sep; 10(27):e2206878. PubMed ID: 37490552
[TBL] [Abstract][Full Text] [Related]
13. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
14. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
15. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
[TBL] [Abstract][Full Text] [Related]
16. Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway.
Guo M; Qiao Y; Lu Y; Zhu L; Zheng L
J Obstet Gynaecol Res; 2023 May; 49(5):1383-1392. PubMed ID: 36843235
[TBL] [Abstract][Full Text] [Related]
17. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract][Full Text] [Related]
18. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
19. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
Sui Z; Zhou J; Cheng Z; Lu P
Tumour Biol; 2015 Aug; 36(8):6173-9. PubMed ID: 25787749
[TBL] [Abstract][Full Text] [Related]
20. SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1/miR-133b/SQLE axis.
Wang S; Dong L; Ma L; Yang S; Zheng Y; Zhang J; Wu C; Zhao Y; Hou Y; Li H; Wang T
J Cell Mol Med; 2022 Jul; 26(13):3636-3647. PubMed ID: 35638462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
